Finding Value in Retail, Drug, Chemical Stocks
Times Staff
The Value Line Investment Survey, a weekly publication that analyzes 1,700 stocks, has upgraded five companies to its top “timeliness” ranking based on projected gains in the coming 12 months.
Bumped up in the latest issue of Value Line, whose top picks have a history of outperforming the broad market, were retailers Bed Bath & Beyond and Tandy, drug companies Mylan Labs and Pharmaceutical Product Development and specialty chemical company MacDermid.
Knocked out of the top tier were Anchor Gaming, Jones Pharmaceuticals, Kmart, Kansas City Southern and Robert Half International.
